Shandong Xinhua Pharmaceutical Co Overview

  • Founded
  • 1943

  • Status
  • Public

  • Employees
  • 6,540

  • Stock Symbol
  • 000756

Stock Symbol
  • Share Price
  • $2.43

  • (As of Wednesday Closing)

Shandong Xinhua Pharmaceutical Co General Information


Shandong Xinhua Pharmaceutical Co Ltd is a pharmaceutical products manufacturer based in China. It operates the business through the following segments: Chemical bulk drugs, Preparations, Chemical intermediates, and other products. The company provides chemical bulk drug products, including metamizole sodium, caffeine, aminopyrine, aspirin, hydrocortisone, pipemidic acid, ibuprofen, and L-dopa, it also dispenses formulation products such as compound liquorice tablets and nimodipine tablets. Its products address disorders related to the central nervous system and the cerebrovascular system with the help of antipyretics and analgesics.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Drug Discovery
Other Industries
Stock Exchange
Primary Office
  • No.1 Lutai Avenue, High-tech Zone
  • Zibo, 255086
  • China
+86 153 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Shandong Xinhua Pharmaceutical Co Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.43 $2.48 $1.14 - $6.07 $1.27B 670M 26.4M $0.08

Shandong Xinhua Pharmaceutical Co Financials Summary

In Thousands,
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 2,258,082 947,400 736,543 685,873
Revenue 1,032,822 1,015,951 869,290 811,333
EBITDA 139,007 139,365 122,574 112,558
Net Income 53,063 53,979 47,022 43,413
Total Assets 1,185,684 1,150,285 1,085,661 919,853
Total Debt 251,030 163,750 166,461 211,473
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Shandong Xinhua Pharmaceutical Co Patents

Shandong Xinhua Pharmaceutical Co Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10399931-B2 Octahydroanthracene compound, preparation method and application thereof Active 20-Apr-2016 0000000000
US-20190071393-A1 Octahydroanthracene compound, preparation method and application thereof Active 20-Apr-2016 0000000000

Shandong Xinhua Pharmaceutical Co Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Shandong Xinhua Pharmaceutical Co Subsidiaries (1)

Company Name Industry Location Founded
00000000 000000 00 Distributors/Wholesale South El Monte, CA 0000
To view Shandong Xinhua Pharmaceutical Co’s complete subsidiaries history, request access »